Drug Development in Pre-Clinical Research

Before testing a drug in people, researchers must determine whether it's the potential to cause serious harm, also called toxicity. the 2 sorts of preclinical research are: In Vitro, In Vivo. Usually, preclinical studies aren't very large. However, these studies must provide detailed information on dosing and toxicity levels. After preclinical testing, researchers review their findings and choose whether the drug should be tested in people.

 

    Related Conference of Drug Development in Pre-Clinical Research

    September 17-18, 2026

    34th International Conference on Nanomedicine & Drug Delivery

    London, UK
    September 21-22, 2026

    39th International Conference on Neonatology and Perinatology

    Barcelona, Spain
    November 25-26, 2026

    19th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology

    Paris, France
    January 18-19, 2027

    42nd International Conference on Advanced Nanotechnology & Nano Electronics

    Paris, France
    January 20-21, 2027

    43rd Global Nanotechnology Congress

    Rome, Italy
    February 18-19, 2027

    27th World Congress on Neonatology and Pediatrics

    Barcelona, Spain
    March 22-23, 2027

    10th International Conference on Nanomedicine and Nanotechnology

    Rome, Italy
    March 25-26, 2027

    30th World Nanotechnology Congress

    Paris, France
    July 05-06, 2027

    6th International Conference on Nano Chemistry & Nano Medicine

    Rome, Italy
    July 20-21, 2027

    38th International Conference and Expo on Nanosciences and Nanotechnology

    Amsterdam, Netherlands

    Drug Development in Pre-Clinical Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in